Geode Capital Management, LLC Imara Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.73 - $5.2 $121,788 - $169,785	32,651 Added 31.07%	137,726 $563,000
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.42 $54,762 - $119,393	49,336 Added 88.51%	105,075 $239,000
Q2 2022 Aug 12, 2022	BUY	$0.99 - $1.87 $1,263 - $2,386	1,276 Added 2.34%	55,739 $68,000
Q1 2022 May 13, 2022	SELL	$1.15 - $2.41 $361 - $756	-314 Reduced 0.57%	54,463 $102,000
Q3 2021 Nov 12, 2021	BUY	$4.08 - $7.83 $13,480 - $25,870	3,304 Added 6.42%	54,777 $223,000
Q2 2021 Aug 13, 2021	SELL	$6.78 - $9.04 $362,533 - $483,377	-53,471 Reduced 50.95%	51,473 $406,000
Q1 2021 May 12, 2021	BUY	$8.18 - $23.98 $21,619 - $63,379	2,643 Added 2.58%	104,944 $885,000
Q4 2020 Feb 12, 2021	BUY	$15.81 - $29.0 $306,476 - $562,165	19,385 Added 23.38%	102,301 $2.26 Million
Q3 2020 Nov 13, 2020	BUY	$18.75 - $28.58 $10,687 - $16,290	570 Added 0.69%	82,916 $1.69 Million
Q2 2020 Aug 13, 2020	BUY	$15.6 - $54.87 $1.28 Million - $4.52 Million	82,346 New	82,346 $2.28 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.